Bei Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Bei Wang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Dongran Han
School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Yixing Liu
School of Management, Beijing University of Chinese Medicine, Beijing, China
2 shared publications - Byoungkwon An
Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA, USA
1 shared publication - Cameron Myhrvold
Princeton University
1 shared publication - Fan Chang
University Student Mental Health Education and Counseling Center, Beijing University of Chinese Medicine, Beijing 102488, China
1 shared publication - Fei Zhang
Department of Chemistry, Rutgers University, Newark, USA
1 shared publication
Latest Publications
- Open Access
- 27 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4820
Integrating Divergence-Based Proteomic Analysis and Directed Network Diffusion to Characterize Diagnosis-Anchored Molecular Variability at the Metabolic Syndrome–Migraine Interface
Metabolic syndrome (MetS) has been associated with migraine, but the prediagnostic phase and the molecular features preceding migraine onset remain unclear. We aimed to identify a diagnosis-anchored proteomic variability window and to characterize pathways, candidate bridge proteins, and druggable targets within a direction-consistent MetS-to-migraine molecular framework. We first assessed the association between baseline MetS and incident migraine in 452,471 UK Biobank participants using Cox models. We then conducted a nested proteomics case–control analysis stratified by MetS status and applied single-sample Jensen–Shannon divergence (sJSD), network proximity, directed diffusion, and drug–target proximity analyses. Baseline MetS was associated with a higher risk of incident migraine (hazard ratio 1.09, 95% confidence interval (CI) 1.01–1.18; p = 0.022). A diagnosis-anchored proteomic divergence pattern peaked 4.71–6.76 years before migraine diagnosis in the MetS stratum. The parallel within-stratum analysis in the NoMetS stratum showed no T2-centered peak. We identified 11 direction-consistent novel pathways, seven candidate bridge proteins spanning metabolic, endothelial, and brain tissues, and three candidate drugs. These findings support a diagnosis-stratified framework for studying MetS-related migraine and provide testable hypotheses for future mechanistic and pharmacological evaluation.
- 27 May 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (11) , 4820
Open AccessIntegrating Divergence-Based Proteomic Analysis and Directed Network Diffusion to Characterize Diagnosis-Anchored Molecular Variability at the Metabolic Syndrome–Migraine Interface
Metabolic syndrome (MetS) has been associated with migraine, but the prediagnostic phase and the molecular features preceding migraine onset remain unclear. We aimed to identify a diagnosis-anchored proteomic variability window and to characterize pathways, candidate bridge proteins, and druggable targets within a direction-consistent MetS-to-migraine molecular framework. We first assessed the association between baseline MetS and incident migraine in 452,471 UK Biobank participants using Cox models. We then conducted a nested proteomics case–control analysis stratified by MetS status and applied single-sample Jensen–Shannon divergence (sJSD), network proximity, directed diffusion, and drug–target proximity analyses. Baseline MetS was associated with a higher risk of incident migraine (hazard ratio 1.09, 95% confidence interval (CI) 1.01–1.18; p = 0.022). A diagnosis-anchored proteomic divergence pattern peaked 4.71–6.76 years before migraine diagnosis in the MetS stratum. The parallel within-stratum analysis in the NoMetS stratum showed no T2-centered peak. We identified 11 direction-consistent novel pathways, seven candidate bridge proteins spanning metabolic, endothelial, and brain tissues, and three candidate drugs. These findings support a diagnosis-stratified framework for studying MetS-related migraine and provide testable hypotheses for future mechanistic and pharmacological evaluation.
- Open Access
- 2 April 2025
- Published by MDPI AG in Behavioral Sciences
- Vol. 15 (4) , 459
A Machine Learning-Based Method for Developing the Chinese Symptom Checklist-11 (CSCL-11)
The Chinese version of the Symptom Checklist-90 (SCL-90) is excessively lengthy, resulting in extended completion time and reduced respondent compliance. This study aimed to utilize a condensed subset of items from the Chinese SCL-90 to identify individuals at high risk for psychological disorders based on machine learning methods, forming a concise and efficient preliminary psychopathological screening instrument for the Chinese general population. Analyzing data collected from 4808 SCL-90 psychological surveys, this study applied variable clustering to select the most representative items, resulting in an 11-item scale: the Chinese Symptom Checklist-11 (CSCL-11). The CSCL-11 demonstrated high internal consistency (Cronbach’s α = 0.84). The results of factor analysis supported a single-factor model for the CSCL-11, demonstrating an acceptable fit (SRMR = 0.035, RMSEA = 0.064, CFI = 0.935, and TLI = 0.919). The CSCL-11 demonstrated strong predictive performance for the Global Severity Index (GSI; RMSE = 0.11, R2 = 0.92, Pearson’s r = 0.96) and various subscale scores (RMSE < 0.25, R2 > 0.70, Pearson’s r > 0.85). Additionally, it achieved a 96% accuracy rate in identifying individuals at high risk for psychological disorders. The comparison results indicated that the CSCL-11 outperformed SCL-14, SCL-K11, and SCL-K-9 in predicting GSI scores. In identifying high-risk groups, CSCL-11 demonstrated performance similar to that of SCL-14 and surpassed both SCL-K11 and SCL-K-9. The CSCL-11 retains most of the critical information from the original Chinese SCL-90 and serves as a preliminary psychopathological screening tool for the Chinese general population.
- 2 April 2025
- Published by MDPI AG in Behavioral Sciences
- Vol. 15 (4) , 459
Open AccessA Machine Learning-Based Method for Developing the Chinese Symptom Checklist-11 (CSCL-11)
The Chinese version of the Symptom Checklist-90 (SCL-90) is excessively lengthy, resulting in extended completion time and reduced respondent compliance. This study aimed to utilize a condensed subset of items from the Chinese SCL-90 to identify individuals at high risk for psychological disorders based on machine learning methods, forming a concise and efficient preliminary psychopathological screening instrument for the Chinese general population. Analyzing data collected from 4808 SCL-90 psychological surveys, this study applied variable clustering to select the most representative items, resulting in an 11-item scale: the Chinese Symptom Checklist-11 (CSCL-11). The CSCL-11 demonstrated high internal consistency (Cronbach’s α = 0.84). The results of factor analysis supported a single-factor model for the CSCL-11, demonstrating an acceptable fit (SRMR = 0.035, RMSEA = 0.064, CFI = 0.935, and TLI = 0.919). The CSCL-11 demonstrated strong predictive performance for the Global Severity Index (GSI; RMSE = 0.11, R2 = 0.92, Pearson’s r = 0.96) and various subscale scores (RMSE < 0.25, R2 > 0.70, Pearson’s r > 0.85). Additionally, it achieved a 96% accuracy rate in identifying individuals at high risk for psychological disorders. The comparison results indicated that the CSCL-11 outperformed SCL-14, SCL-K11, and SCL-K-9 in predicting GSI scores. In identifying high-risk groups, CSCL-11 demonstrated performance similar to that of SCL-14 and surpassed both SCL-K11 and SCL-K-9. The CSCL-11 retains most of the critical information from the original Chinese SCL-90 and serves as a preliminary psychopathological screening tool for the Chinese general population.
- 15 December 2017
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 358 (6369)
Single-stranded DNA and RNA origami
Large origami from a single strand: Nanostructures created by origami-like folding of nucleic acids are usually formed by base-pairing interactions between multiple strands. Han et al. show that large origami (up to 10,000 nucleotides for DNA and 6000 nucleotides for RNA) can be created in simple shapes, such as a rhombus or a heart. A single strand can be folded smoothly into structurally complex but knot-free structures by using partially complemented double-stranded DNA and the cohesion of parallel crossovers. The use of single strands also enables in vitro synthesis of these structures. Science , this issue p. eaao2648
- 15 December 2017
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 358 (6369)
Single-stranded DNA and RNA origami
Large origami from a single strand: Nanostructures created by origami-like folding of nucleic acids are usually formed by base-pairing interactions between multiple strands. Han et al. show that large origami (up to 10,000 nucleotides for DNA and 6000 nucleotides for RNA) can be created in simple shapes, such as a rhombus or a heart. A single strand can be folded smoothly into structurally complex but knot-free structures by using partially complemented double-stranded DNA and the cohesion of parallel crossovers. The use of single strands also enables in vitro synthesis of these structures. Science , this issue p. eaao2648